Market Closed -
Nyse
04:10:00 2024-07-05 pm EDT
|
5-day change
|
1st Jan Change
|
1.05
USD
|
-0.01%
|
|
+10.52%
|
-4.55%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,062
|
805.9
|
776.2
|
551.6
|
491.1
|
339
|
Enterprise Value (EV)
1 |
1,784
|
2,584
|
2,796
|
3,127
|
3,573
|
3,577
|
P/E ratio
|
-2.96
x
|
-1.46
x
|
-1.17
x
|
-0.68
x
|
-1.01
x
|
-1.15
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
5.56
x
|
4.06
x
|
3.48
x
|
1.14
x
|
1.04
x
|
0.63
x
|
EV / Revenue
|
9.35
x
|
13
x
|
12.5
x
|
6.44
x
|
7.57
x
|
6.66
x
|
EV / EBITDA
|
-7.17
x
|
-8.47
x
|
-11.8
x
|
-8.59
x
|
-8.89
x
|
-10.4
x
|
EV / FCF
|
-3.12
x
|
-6.01
x
|
-3.89
x
|
-3.31
x
|
-4.78
x
|
-68.9
x
|
FCF Yield
|
-32%
|
-16.6%
|
-25.7%
|
-30.2%
|
-20.9%
|
-1.45%
|
Price to Book
|
2.43
x
|
-6.57
x
|
-1.17
x
|
-0.4
x
|
-0.26
x
|
-0.16
x
|
Nbr of stocks (in thousands)
|
43,385
|
43,393
|
43,414
|
43,417
|
43,417
|
43,417
|
Reference price
2 |
24.48
|
18.57
|
17.88
|
12.70
|
11.31
|
7.807
|
Announcement Date
|
4/30/19
|
4/30/20
|
10/15/21
|
4/29/22
|
4/19/23
|
4/19/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
190.9
|
198.4
|
223
|
485.6
|
472.1
|
537.4
|
EBITDA
1 |
-248.8
|
-304.9
|
-236.7
|
-363.9
|
-401.9
|
-344.2
|
EBIT
1 |
-293.8
|
-361.2
|
-307.5
|
-458.3
|
-525
|
-463
|
Operating Margin
|
-153.91%
|
-182.09%
|
-137.89%
|
-94.38%
|
-111.22%
|
-86.15%
|
Earnings before Tax (EBT)
1 |
-225.2
|
-391.1
|
-441.7
|
-529.2
|
-839.9
|
-555.6
|
Net income
1 |
-234.9
|
-307
|
-310
|
-271.4
|
-489.7
|
-297.7
|
Net margin
|
-123.04%
|
-154.79%
|
-139%
|
-55.89%
|
-103.72%
|
-55.39%
|
EPS
2 |
-8.283
|
-12.73
|
-15.34
|
-18.79
|
-11.21
|
-6.814
|
Free Cash Flow
1 |
-571.4
|
-430
|
-718
|
-944.3
|
-747.5
|
-51.94
|
FCF margin
|
-299.32%
|
-216.79%
|
-321.94%
|
-194.46%
|
-158.33%
|
-9.67%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/30/19
|
4/30/20
|
10/15/21
|
4/29/22
|
4/19/23
|
4/19/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
722
|
1,778
|
2,020
|
2,575
|
3,082
|
3,238
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-2.903
x
|
-5.831
x
|
-8.533
x
|
-7.078
x
|
-7.668
x
|
-9.407
x
|
Free Cash Flow
1 |
-571
|
-430
|
-718
|
-944
|
-747
|
-51.9
|
ROE (net income / shareholders' equity)
|
-12.6%
|
-15.3%
|
-18.8%
|
-20.3%
|
-32.3%
|
-28.2%
|
ROA (Net income/ Total Assets)
|
-4.56%
|
-5.08%
|
-3.99%
|
-4.95%
|
-5.36%
|
-4.8%
|
Assets
1 |
5,149
|
6,041
|
7,768
|
5,479
|
9,128
|
6,202
|
Book Value Per Share
2 |
10.10
|
-2.830
|
-15.30
|
-31.60
|
-42.90
|
-48.90
|
Cash Flow per Share
2 |
9.330
|
1.710
|
7.700
|
3.620
|
3.650
|
1.340
|
Capex
1 |
764
|
701
|
505
|
761
|
384
|
116
|
Capex / Sales
|
400.42%
|
353.35%
|
226.31%
|
156.62%
|
81.29%
|
21.53%
|
Announcement Date
|
4/30/19
|
4/30/20
|
10/15/21
|
4/29/22
|
4/19/23
|
4/19/24
|
|
1st Jan change
|
Capi.
|
---|
| -4.55% | 45.58M | | +18.33% | 83.89B | | -28.29% | 71.08B | | +1.34% | 26.77B | | +3.67% | 17.74B | | -9.99% | 17.24B | | +1.86% | 15.6B | | +79.98% | 13.84B | | -25.09% | 12.92B | | +74.41% | 12.87B |
Other Healthcare Facilities & Services
|